GBT
RMD icon

Grove Bank & Trust’s ResMed RMD Stock Holding History

Grove Bank & Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5K Sell
95
-1
-1% -$207 ﹤0.01% 575
2026
Q1 		$21.6K Buy
96
+1
+1% +$249 ﹤0.01% 532
2025
Q4 		$22.9K Hold
95
– – ﹤0.01% 525
2025
Q3 		$26K Hold
95
– – ﹤0.01% 506
2025
Q2 		$24.5K Buy
95
+11
+13% +$2.62K ﹤0.01% 507
2025
Q1 		$18.8K Buy
84
+54
+180% +$12.6K ﹤0.01% 526
2024
Q4 		$6.86K Buy
30
+16
+114% +$3.85K ﹤0.01% 567
2024
Q3 		$3.42K Buy
+14
New +$3.13K ﹤0.01% 593
2024
Q1 		– Sell
-49
Closed -$8.43K – 596
2023
Q4 		$8.43K Hold
49
– – ﹤0.01% 504
2023
Q3 		$7.25K Buy
49
+33
+206% +$5.97K ﹤0.01% 548
2023
Q2 		$3.5K Hold
16
– – ﹤0.01% 577
2023
Q1 		$3.5K Buy
+16
New +$3.47K ﹤0.01% 597

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Grove Bank & Trust's RMD Position: Q2 2026 in Review

Grove Bank & Trust reduced its ResMed (RMD) stake by 1% in Q2 2026, selling an estimated $207 and leaving 95 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Grove Bank & Trust first reported a position in RMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $26K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Grove Bank & Trust held 95 shares of ResMed worth $18.5K as of Q2 2026.
  • Grove Bank & Trust sold 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #575 holding.
  • Grove Bank & Trust first reported a position in ResMed in Q1 2023 and has held it in 12 quarters since.
  • Grove Bank & Trust's ResMed position peaked at $26K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.